Latest Conference Coverage

Why Learning About Masculine Norms Can Improve MS Care

In Part 1 of this interview, the clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research provides in-depth insight on his study evaluating masculinity norms in patients with multiple sclerosis.

Open-Label Extension: BTKI in Relapsing MS Over 108 Weeks

CMSC Data Release: Abstract DXT58 and MS Risk Reduction

Open-Label Extension: Phase 3 OPERA I and II Trials in Relapsing MS

Post Hoc Analysis: Phase 3 EXPAND Trial in Secondary Progressive MS

Primary Results From the ENSEMBLE PLUS Study

Post Hoc Analysis: Phase 3 ASCLEPIOS I and II Trials in Relapsing MS

Ocrelizumab Compared to Glatiramer Acetate and Dimethyl Fumarate for MS

Progressive MS: The 2020 Whitaker Lecture

The Multidisciplinary Theme of CMSC 2020

AHS 2020: What to Expect From the Annual Scientific Meeting

Ahead of sessions kicking off on June 13, Jessica Ailani, MD, FAHS, offers a look into what data, plenary talks, and developments are set to be presented at the upcoming AHS 2020 annual meeting.

Bryan Davis, PsyD, MS: Behavioral Health and CMNI in Treating MS

The clinical health psychology fellow at the Mellen Center for MS Treatment and Research at Cleveland Clinic details the use of behavioral health and potential use of Conformity to Masculine Norms Inventory (CMNI) tool in multiple sclerosis care.

Jessica Ailani, MD: The Ongoing Expansion in Headache Medicine

The AHS fellow, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital spoke to the rapid expansion of headache medicine and what new research will be discussed at AHS 2020.

Jessica Ailani, MD: Plenary Talks at the AHS 2020 Annual Meeting

The AHS fellow, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital discussed what topics the plenary talks will cover at AHS 2020.

Natalizumab Sets Itself Apart From Other MS Treatments

Carrie Hersh, DO, MSc, assistant professor of neurology at the Cleveland Clinic Lerner College of Medicine, discusses recent data on natalizumab as well as what sets it apart from other multiple sclerosis treatments.

Jessica Ailani, MD: What to Expect From the American Headache Society Meeting

The AHS fellow, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital spoke to what to expect from this year’s annual scientific meeting.

Fernando Dangond, MD, MBA: Phase 2 Data on Evobrutinib in MS

Head of Global Clinical Development in Neurology at EMD Serono discussed the findings of a phase 2 assessment of the company’s investigational BTK inhibitor evobrutinib in multiple sclerosis.

Novel BTK Inhibitor Evobrutinib Displays Long-Term Success in MS

The vice president of Global Program Leadership in Neurology and Immunology at EMD Serono discussed the recent long-term phase 2 data on evobrutinib presented at CMSC 2020.

CMSC 2020 Day 4: Sarah Morrow, MD, MS, on a Clinician's Guide to Cognition in MS

Sarah Morrow, MD, MS, presents her lecture titled, "A Clinician’s Guide to Cognition in MS" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 4: Jennifer Graves, MD, PhD, on the Role of Biological Aging in MS Progression

Jennifer Graves, MD, PhD, presents her lecture titled, "The Role of Biological Aging in MS Progression" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 4: Riley Bove, MD, on Caring for Women Across the Reproductive Lifespan

Riley Bove, MD, presents her lecture titled, "Caring for Women Across the Reproductive Lifespan" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 4: Horea Rus, MD, PhD, on the Role of Complement in MS

Horea Rus, MD, PhD, delivers his lecture titled, "The Role of Complement in MS" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 4: Sergio Baranzini, PhD With a Genetics Update in MS

Sergio Baranzini, PhD, presents his lecture titled, "Genetics Update" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 3: Mark Freedman, MSc, MD, on Stem Cell Research

Mark Freedman, MSc, MD, presents the John F. Kurtzke Lecture, titled "Stem Cell Research Update" as part of the 2020 CMSC Virtual Annual Meeting.

Aerobic Exercise Shows Positive Effect in Multiple Sclerosis

Improvements in function may be mediated by an effect of aerobic fitness on deep gray matter brain structures.

Cladribine Deemed Well-Tolerated in MS Treatment, Could Influence Adherence Rates

An analysis of data from the phase 3 development of cladribine (Mavenclad; EMD Serono) showed that the incidence of treatment-emergent adverse events was low and most were mild in intensity.

CMSC 2020 Day 3: Laura Safar, MD on Use of Psychotropics in MS

Laura Safar, MD, presents her lecture titled, "Use of Psychotropics in MS: Antidepressants, Anti-anxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive Enhancers" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 3: Allen Bowling, MD, PhD, on Cannabis and MS

Allen Bowling, MD, PhD, presents his lecture titled, "Cannabis and MS: Efficacy, Safety, Drug Interactions, and Research Update" as part of the 2020 CMSC Virtual Annual Meeting.

CMSC 2020 Day 3: Benjamin Greenberg, MD, on Emerging Therapies Across the Disease Spectrum

Benjamin Greenberg, MD, presents his lecture titled, "Emerging Therapies Across the Disease Spectrum" as part of the 2020 CMSC Virtual Annual Meeting.

Peter Nakaji, MD: The State of Science for Epilepsy Surgery

The chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.